Mobile Lads Corporation (CE) (MOBO) Quote

Dead in the water.
No filings.

And now stacking the ask, ridiculous. Surprised this hasn't had a bounce over .01 yet.

Scam MMs. They can fill higher then if f they want to play games

This one is long overdue for a nice bounce MOBO

Yeah I think so too. Should get back over .01… lots bought .01-05 in the last 6 months

Yeah we’ll have to keep an eye. They have to have come from somewhere. As long as seller stays away this will be back to high dubs on air

How is this trading all of a sudden no news at all dose someone No something

Could be. I guess we'll see how it plays out next week, but some nice support in this area, I think the selling will dry up at this level and we see a bounce eventually. L2 ask was wide open going into today

WOW 4 million.

Crazy man… just blowing out bids… maybe some restricted came free? Seems insane for anyone to selling down here

Grabbed a few down here, but OTCN diluting heavy today, let's see if he let's it breathe eventually

Not seeing any recent changes in SS but something doesn’t feel right… let’s see , maybe some eoy tax selling… strange

MOBO .004 and below?

$MOBO looking good $$

Just the beginning, my friend.

Mega dumperoooo

Dumping officially started.

Looks like someone’s sitting on a lot of cheap shares keep selling.
It’s not going anywhere anytime soon.

Good day today $MOBO

How is it all bud and the ticker is going down lol

All that good news and company still trades at 0.013.

The pr's line up....
first there is talk about. Electromedical surrounding. Magic mushrooms....
So the intelligent among us. Rules out recreational magic mushrooms and starts looking at the opportunity. The opportunity in the medical area.
Then we see. An acquisition of AVAIL labs.
Next we see. A PR. About $6 million. Revenue potential in South Florida from the. CEO of a male labs.
Then we see a $25 million line of credit for the. Purchase. Of these electromedical devices, which will allow experts to read the neural pathways in. Suicidal. Veterans. In people who are addicted to heroin, in alcoholics, et cetera,
I am beginning to see. On the wall.
The future for Magic mushrooms. I would say Silocybin, if I could spell it easily.
The future is in medicine, not in recreation. Make note of that. Everybody.

Apparently no interest here…

www.bitcoinonline.today

$mobo... I believe the stars are lining up properly. For the. Story on this stock. To be shown to many more people in the next month than in the last three months./
Draw your own conclusions with respect to what might happen with the. vol + the price.

$MOBO STOCK - http://PubMed.gov Clinical studies show Psilocybin use reduces odds of Opioid Use Disorder.. #psychedelics #otc #biotech #psilocybin #mobo #mentalhealth #addiction #oud #opioidusedisorder https://pubmed.ncbi.nlm.nih.gov/35393455/

$MOBO STOCK - https://t.co/h7o4NkEz3b Clinical studies show Psilocybin use reduces odds of Opioid Use Disorder.. #psychedelics #otc #biotech #psilocybin #mobo #mentalhealth #addiction #oud #opioidusedisorder https://t.co/KRJHMriJMU— Avail Scientific (@AVAILSCIENCE) February 6, 2023

CEO and CRO in place. Let’s go $MOBO

Avail Scientific Appoints Gerard Maynard as Chief Revenue Officer



Jan 31, 2023 (ACCESSWIRE via COMTEX) -- TORONTO, ON / ACCESSWIRE / January 31, 2023 / MOBILE LADS, CORP., dba AVAIL SCIENTIFIC (OTC PINK:MOBO), is pleased to announce Gerard Maynard as Chief Revenue Officer ("CRO"). Following Avail's January 10th, 2023, Letter of Intent that outlined the terms for the acquisition of Relai Neuro at which Gerard Maynard is currently President. Gerard has over twenty years of experience building, and leading successful sales organizations, in digital marketing, healthcare, technology and IT management.

"I couldn't be more thrilled to join such an amazing organization as Avail Scientific. With Avail's new venture into neurological testing, data management as well as strategic partnerships in the mental health industry. This is a golden opportunity to drive revenues via Avail's neurological testing and analytics while building our strategic partnerships and long-term value. Avail is poised to have exponential growth over the next few years. I feel very fortunate to be a party of such a talented team" statement from Gerard Maynard Relai Neuro provides neurological testing and data management to rehab and mental health treatment centers in Florida. Avail Scientific's (MOBO) mandate is to support psychedelic medicine research and treatments through neurological testing, data analytics, and data management.

Website: https://www.relaineuro.com

Website: https://www.availscientific.com/

https://www.marketwatch.com/press-release/avail-scientific-appoints-gerard-maynard-as-chief-revenue-officer-2023-01-31?mod=mw_quote_news_seemore

https://goldstartrades.com $MOBO. 5 reasons to pick up MOBO....eom.

An exciting story in the area of psychedelic research plus addiction treatment.


$MOBO... As you can see from the notes on my chart... In the short term we are looking at A 3 bagger = 4 to 12 cents...
But then Fundys take over = and we see Dollar sign trading !!!
An exciting story in the area of psychedelic research plus addiction treatment.#psychedelic https://t.co/VoLg8cJqHu pic.twitter.com/NsLkTmsCP7— @stewdomer (@stewdomer) January 27, 2023

$MOBO STOCK - Latest News!! Relai Neuro CEO
Appointed as Interim
CEO to Avail Scientific..#psychedelics #otc #biotech #mobo #psilocybin #addiction #mentalhealth #opioidusedisorder https://t.co/lf931zYOb2— Avail Scientific (@AVAILSCIENCE) January 26, 2023

Relai Neuro CEO Appointed as Interim CEO to Avail Scientific


TORONTO, ON / ACCESSWIRE / January 26, 2023 / MOBILE LADS CORP, doing business as AVAIL SCIENTIFIC ("AVAIL") / (OTC PINK:MOBO) is pleased to announce Dr. James Thompson will be appointed as Interim CEO of Avail Scientific. This appointment follows Avail's January 10th, 2023 announcement of having signed a Letter of Intent that outlined the terms for the acquisition of Relai Neuro at which Dr. Thompson is currently CEO.

Dr. Thompson's professional experience in neurological testing and analytics, his work in founding, growing, and consulting with medical technology companies, and his passion for the mental health space will be instrumental in guiding Avail Scientific's pursuit of supporting psychedelic medicine research and treatments through neurological testing, data analytics, and data management.

Dr. Thompson states, "I am excited to help lead Avail Scientific. One of my first goals will be to build out our management team as well as to establish key strategic partnerships over the next few months in order to position us to achieve our collective mission."

Current CEO, Michael Paul will retain his role as President and Chairman of the Board of Directors of Avail. "We are excited to have Dr. Thompson take on the Interim CEO role at Avail as it aligns itself with Relai Neuro to become a much stronger single company. We are confident that Dr. Thompson can help drive the company toward its goal of becoming a world leader in the development of psychedelic therapeutics for the treatment of addiction & mental health issues," said Michael Paul.


https://finance.yahoo.com/news/relai-neuro-ceo-appointed-interim-150000986.html

Something big is coming by now before it’s to late

Hearing whispers of press this week..

$MOBO Hmmmm LOI, interesting acquisition target. Let’s see some #’s

Avail Scientific Signs LOI to Acquire Florida Neurological Testing Company Relai Neuro

Jan 19, 2023 (ACCESSWIRE via COMTEX) -- TORONTO, ON / ACCESSWIRE / January 19, 2023 / AVAIL SCIENTIFIC (OTC PINK:MOBO) is pleased to announce it is entering into a letter of intent (LOI) to acquire Florida based Relai Neuro LLC which provides Neurological testing and data management.

This acquisition will allow Relai to double its sales force over the next three months as well as expand services into California, Texas, and Colorado.

Dr. James Thompson, CEO of Relai Neuro, says; "We are excited to work with Avail Scientific. The acquisition will allow us to bolster our offerings and our team. Additionally, the acquisition of Relai will allow us to achieve our goals of expansion in Florida, as well as expand quickly into California, Texas, and Colorado markets."

"Relai Nero allows Avail to continue to accelerate our treatment applications, testing and supporting data collection as we strive to become a world leader in the clinically studied and supported use of psychedelic therapeutics for treatment of addiction & mental health issues," says Avail CEO, Michael Paul.

Relai Neuro provides neurological testing and data management to rehab and mental health treatment centres in Florida.

Relai's products and methodology allow for the direct measurement of progress in neural functions of patients under various treatments. For example, Relai is currently measuring the effects of Psilocybin micro-dosing on addiction in patients within a clinical environment.

RelaiNeuro - https://nusqu.com/relaineuro

https://www.marketwatch.com/press-release/avail-scientific-signs-loi-to-acquire-florida-neurological-testing-company-relai-neuro-2023-01-19?mod=mw_quote_news_seemore

$MOBO STOCK - 5 Reasons We Believe OTC: MOBO & Psychedelic Therapeutics Could Be a Big Winner for Investors in 2023! Read more.. & Subscribe.. #Psychedelics #mobo #otc #biotech #Psilocybin #addiction #mentalhealth #opioidusedisorder https://goldstartrades.com


$MOBO STOCK - 5 Reasons We Believe OTC: MOBO & Psychedelic Therapeutics Could Be a Big Winner for Investors in 2023! Read more.. & Subscribe.. #Psychedelics #mobo #otc #biotech #Psilocybin #addiction #mentalhealth #opioidusedisorder https://t.co/7WnBcB6icQ pic.twitter.com/NFsmrJn8qN— Avail Scientific (@AVAILSCIENCE) January 9, 2023

Wow some good news

“Avail Scientific has been evaluating several promising ventures with research organizations and manufacturing laboratories for some time and expects to conclude several business partnerships in the near-term.”

Mobile Lads/Avail Scientific to Enter the Neurological Testing and Data Management Area with A Continued Emphasis on Monitoring the Effectiveness of Psychedelic Medicines in Mental Health Treatment Via Software and Hardware Systems


Avail Scientific will be focusing its efforts on neurological data acquisition, data analysis, and data management with the explicit goal of better understanding and improving patient outcomes in multiple neurological disorders, with an initial focus on mental health and addiction.

Avail Scientific is continuing to establish key partners in the psychedelic medicine space to monitor the effectiveness and efficacy of Psychedelic medicines in mental health treatment as these modalities continue to demonstrate heightened effectiveness and gain regulatory acceptance.

Avail Scientific has been evaluating several promising ventures with research organizations and manufacturing laboratories for some time and expects to conclude several business partnerships in the near-term.

Avail Scientific's mandate is to support neurological, psychedelic and other medical research and treatments through neurological testing, data analytics and data management.


https://www.marketwatch.com/press-release/mobile-ladsavail-scientific-to-enter-the-neurological-testing-and-data-management-area-with-a-continued-emphasis-on-monitoring-the-effectiveness-of-psychedelic-medicines-in-mental-health-treatment-via-software-and-hardware-systems-2023-01-06?mod=mw_quote_news_seemore

Mobile Lads/Avail Scientific to Enter the Neurological Testing and Data Management Area with A Continued Emphasis on Monitoring the Effectiveness of Psychedelic Medicines in Mental Health Treatment Via Software and Hardware Systems


Avail Scientific will be focusing its efforts on neurological data acquisition, data analysis, and data management with the explicit goal of better understanding and improving patient outcomes in multiple neurological disorders, with an initial focus on mental health and addiction.

Avail Scientific is continuing to establish key partners in the psychedelic medicine space to monitor the effectiveness and efficacy of Psychedelic medicines in mental health treatment as these modalities continue to demonstrate heightened effectiveness and gain regulatory acceptance.

Avail Scientific has been evaluating several promising ventures with research organizations and manufacturing laboratories for some time and expects to conclude several business partnerships in the near-term.

Avail Scientific's mandate is to support neurological, psychedelic and other medical research and treatments through neurological testing, data analytics and data management.


https://www.marketwatch.com/press-release/mobile-ladsavail-scientific-to-enter-the-neurological-testing-and-data-management-area-with-a-continued-emphasis-on-monitoring-the-effectiveness-of-psychedelic-medicines-in-mental-health-treatment-via-software-and-hardware-systems-2023-01-06?mod=mw_quote_news_seemore

$MOBO News: “Mobile Lads/Avail Scientific to Enter the Neurological Testing and Data Management Area with A Continued Emphasis on Monitoring the Effectiveness of Psychedelic Medicines in Mental Health Treatment Via Software and Hardware Systems”

https://www.otcmarkets.com/stock/MOBO/news/story?e&id=2418434

https://www.otcmarkets.com/stock/MOBO/news?id=385528

Looks like it

Yes something big is coming

MOBO nice quiet climber …… hmmmm

sweet. $MOBO $$

$MOBO SS float reduction

$MOBO

??0.0140
Pink Current, AS: 950M, OS: 368M, US: 172M

Restricted Shares Updated:
- 143,296,294 (2022-11-15)
+ 196,096,294 (2022-12-12)
Difference: +36.8% (+52M)

Unrestricted Shares Updated:
- 225,698,590 (2022-11-15)
+ 172,898,590 (2022-12-12)
Difference: -23.4% (-52M)

Chart, OTC Profile, Twitter, @otcupdates

Update: 2022-12-13 15:16:52 (UTC)

Something big is coming for sure

Something brewing